FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015910836> ?p ?o ?g. }

• W3015910836 endingPage "106358" @default.
• W3015910836 startingPage "106358" @default.
• W3015910836 abstract "Vincristine is the first-line drug for the chemotherapy of canine transmissible venereal tumor (CTVT). Drug resistance is related to tumor cyto-morphological patterns of CTVT. There are anti-cancer properties of ivermectin, thus, a combination of ivermectin and vincristine could be an effective chemo-therapeutic treatment regimen for CTVT. Study aims, therefore, were to (1) assess the frequency of CTVT cyto-morphologies, and (2) evaluate treatment efficacy and possible adverse reactions to vincristine compared with a combination vincristine and ivermectin. Dogs (n = 41) with CTVT were characterized by tumor cyto-morphology and disease severity and of those, 20 were randomly allocated into two groups. There was a control group (G-Vin; n = 10) in which there was treatment with vincristine; and an experimental group (G-Iv/Vin; n = 10) in which there was treatment with the ivermectin/vincristine combination. Although dogs in the G-Iv/Vin group had more severe disease at the beginning of the study (P = 0.0031), the number of weeks and chemotherapy sessions until tumor remission were similar among dogs of the two groups, indicating both treatments were effective. There was a decrease in the leukocyte counts (P = 0.0020), related to neutropenia (P = 0.0371) in the G-Vin but not the G-Iv/Vin treatment group. There was no tumor resistance that developed during the study regardless of the treatment regimen used or tumor cytomorphology. In summary, the use of the vincristine/ivermectin combination was well tolerated and efficacious for CTVT treatment." @default.
• W3015910836 created "2020-04-17" @default.
• W3015910836 creator A5005050185 @default.
• W3015910836 creator A5012052830 @default.
• W3015910836 creator A5037544281 @default.
• W3015910836 creator A5039014016 @default.
• W3015910836 creator A5064072731 @default.
• W3015910836 creator A5077556893 @default.
• W3015910836 creator A5089268500 @default.
• W3015910836 date "2020-05-01" @default.
• W3015910836 modified "2023-10-16" @default.
• W3015910836 title "Vincristine and ivermectin combination chemotherapy in dogs with natural transmissible venereal tumor of different cyto-morphological patterns: A prospective outcome evaluation" @default.
• W3015910836 cites W1549489897 @default.
• W3015910836 cites W1567757606 @default.
• W3015910836 cites W1846939808 @default.
• W3015910836 cites W1965628169 @default.
• W3015910836 cites W1971345493 @default.
• W3015910836 cites W1977584573 @default.
• W3015910836 cites W1980930218 @default.
• W3015910836 cites W1982489323 @default.
• W3015910836 cites W1990978302 @default.
• W3015910836 cites W1995565286 @default.
• W3015910836 cites W1999950772 @default.
• W3015910836 cites W2012306916 @default.
• W3015910836 cites W2014238700 @default.
• W3015910836 cites W2024849937 @default.
• W3015910836 cites W2038293434 @default.
• W3015910836 cites W2044300621 @default.
• W3015910836 cites W2045783135 @default.
• W3015910836 cites W2057991257 @default.
• W3015910836 cites W2073795369 @default.
• W3015910836 cites W2078514317 @default.
• W3015910836 cites W2139793844 @default.
• W3015910836 cites W2152453387 @default.
• W3015910836 cites W2191793963 @default.
• W3015910836 cites W2280099304 @default.
• W3015910836 cites W2338264110 @default.
• W3015910836 cites W2509663630 @default.
• W3015910836 cites W2574419884 @default.
• W3015910836 cites W2587955855 @default.
• W3015910836 cites W2756004186 @default.
• W3015910836 cites W2756766403 @default.
• W3015910836 cites W2791066818 @default.
• W3015910836 cites W2798262561 @default.
• W3015910836 cites W2886628217 @default.
• W3015910836 cites W2891020281 @default.
• W3015910836 cites W2941280883 @default.
• W3015910836 cites W2949800055 @default.
• W3015910836 cites W2966830776 @default.
• W3015910836 cites W4249710322 @default.
• W3015910836 doi "https://doi.org/10.1016/j.anireprosci.2020.106358" @default.
• W3015910836 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32414469" @default.
• W3015910836 hasPublicationYear "2020" @default.
• W3015910836 type Work @default.
• W3015910836 sameAs 3015910836 @default.
• W3015910836 citedByCount "2" @default.
• W3015910836 countsByYear W30159108362021 @default.
• W3015910836 crossrefType "journal-article" @default.
• W3015910836 hasAuthorship W3015910836A5005050185 @default.
• W3015910836 hasAuthorship W3015910836A5012052830 @default.
• W3015910836 hasAuthorship W3015910836A5037544281 @default.
• W3015910836 hasAuthorship W3015910836A5039014016 @default.
• W3015910836 hasAuthorship W3015910836A5064072731 @default.
• W3015910836 hasAuthorship W3015910836A5077556893 @default.
• W3015910836 hasAuthorship W3015910836A5089268500 @default.
• W3015910836 hasConcept C126322002 @default.
• W3015910836 hasConcept C143998085 @default.
• W3015910836 hasConcept C2776694085 @default.
• W3015910836 hasConcept C2776755627 @default.
• W3015910836 hasConcept C2777499811 @default.
• W3015910836 hasConcept C2779429289 @default.
• W3015910836 hasConcept C2781413609 @default.
• W3015910836 hasConcept C42972112 @default.
• W3015910836 hasConcept C71924100 @default.
• W3015910836 hasConcept C98274493 @default.
• W3015910836 hasConceptScore W3015910836C126322002 @default.
• W3015910836 hasConceptScore W3015910836C143998085 @default.
• W3015910836 hasConceptScore W3015910836C2776694085 @default.
• W3015910836 hasConceptScore W3015910836C2776755627 @default.
• W3015910836 hasConceptScore W3015910836C2777499811 @default.
• W3015910836 hasConceptScore W3015910836C2779429289 @default.
• W3015910836 hasConceptScore W3015910836C2781413609 @default.
• W3015910836 hasConceptScore W3015910836C42972112 @default.
• W3015910836 hasConceptScore W3015910836C71924100 @default.
• W3015910836 hasConceptScore W3015910836C98274493 @default.
• W3015910836 hasFunder F4320308925 @default.
• W3015910836 hasFunder F4320321091 @default.
• W3015910836 hasFunder F4320322025 @default.
• W3015910836 hasFunder F4320323681 @default.
• W3015910836 hasLocation W30159108361 @default.
• W3015910836 hasOpenAccess W3015910836 @default.
• W3015910836 hasPrimaryLocation W30159108361 @default.
• W3015910836 hasRelatedWork W12501893 @default.
• W3015910836 hasRelatedWork W14228319 @default.
• W3015910836 hasRelatedWork W14327771 @default.
• W3015910836 hasRelatedWork W15357374 @default.
• W3015910836 hasRelatedWork W15521606 @default.
• W3015910836 hasRelatedWork W17155469 @default.

• next